Pharma's Almanac TV
PA TV
Your Name
Your Email
Manage Account
Sign Out
Sign In
Register
Follow the Journey
Companies On The Road
Arcadis DPS Group
C2 Pharma
CAI
EcoLab
Environmental Systems Corporation
Federal Equipment Company
Globyz Biopharma Services
Grifols
Integrity
Nu-Tek BioSciences
PHARMALEX
Waters Corporation
Follow the Journey
Companies On The Road
ABS
aCGT Vector
Alconox Inc.
Andelyn Biosciences
Arranta Bio
Avid Bioservices
BDD
BIOVECTRA
DPS Group
Dynamk Capital
Environmental Systems Corporation
Federal Equipment Company
Genesis AEC
Globyz Biopharma Services
Grifols Partnership
IDT Biologika
Inceptor Bio
IPS-Integrated Project Services
Kineticos Life Sciences
MilliporeSigma
Montana BioScience Alliance
Olon
Rentschler Biopharma
SanaClis
Scorpion Biological Services
Secant Group
Tapemark
VITRONIC
Follow the Journey
Companies On The Road
AES Clean Technology
Altis Biosystems
Arranta Bio
Avara Pharmaceutical Services
Avid Bioservices
BioVectra
Centaur BPS
Dynamk Capital
ECRI
Evolve Biologics
Federal Equipment Company
Globyz
Inceptor Bio
IPS-Integrated Project Services
Olon
Pii
Polpharma Biologics
PPD
RoosterBio
SanaClis
Sanofi AIS
SGD Pharma
SPI Pharma
TriRx Pharmaceutical Services
Yourway
Dashboard
Topics
Products
ADC
API - Small Molecule
Biologics
Biopharmaceuticals
Biosimilars
Cell and Gene Therapy
DNA
Drug Product
Drug Substance
Equipment
Generics
Immunotherapy
Injectables
Monoclonal Antibody
Novel Therapeutics
Oral Solid Dosage
Orphan Drugs
Parenterals
Stem Cells
Vaccine
Services
Big Data
Bioprocessing
Clinical Trials
Continuous Manufacturing
Diagnostics
Drug Delivery
Drug Development
Drug Discovery
Facility
Formulation
Innovation
Oncology
Patient Adherence
Patient Centric
Preclinical
Process Development
Quality
Regulatory
Research
Serialization
Segment
Biomanufacturing
Biotechnology
CDMO
Consulting
CRO
Engineering
Equipment
Excipients
Healthcare
Intermediates
Logistics
Manufacturing
Packaging
Supply Chain
Business
Agreement
Appointment
Business
Capacity Expansion
Collaboration
Growth
Investment
Licensing
M&A
Market Expansion
Market Intelligence
Market Prediction
New Facility
Strategic Partnership
Magazine
Archive
Reports
Nice Insight Reports
2022 Sterile
2023 Cell & Gene Therapy
2023 mAb and Recombinant Protein
2024 API
2024 OSD
2024 ADC
2024 mRNA
2024 Mammalian Cell Culture
2024 Microbial Cell Culture
2024 Plasmids
2024 Gene Therapy
2024 Cell Therapy
2024 Sterile
Community
Company A to Z
Follow the Journey
Companies On The Road
Follow The Artist
Follow the Journey
Companies On The Road
More+
Staffing
Media Kit
Cell and Gene Therapy (4)
240 Articles Available
4
10
Can't find what you're looking for? Try our
advanced search
.
CRISPR-Cas9
How Close Is CRISPR to Eradicating Disease and Correcting Genetic Defects?
PAP-Q1-20-NI-003
Cell and Gene Therapy
Visualizing the Future of Contract Development and Manufacturing for Cell and Gene Therapies
PAP-Q1-20-CL-039
M&A
Abcam Expands Cell Engineering Capabilities Through Asset Purchase of Applied StemCell's Gene Editing Platform and Oncology Product Portfolio
PR-M02-20-NI-007
M&A
Catalent Acquires Orgenesis' Cell Therapy Unit
PR-M01-20-NI-046
Cell and Gene Therapy
The Center for Breakthrough Medicines to Build a Cell and Gene Therapy CDMO in King of Prussia, PA
PR-M01-20-NI-035
Isolators
Isolator Design for Cell Therapy Facilities
PAP-Q3-19-CL-009
AAV
WuXi Advanced Therapies Launches New World-Class AAV Vector Suspension Platform
PR-M01-20-NI-017
Cell and Gene Therapy
BC Platforms Partners with Dante Labs to Build Europe’s Largest Next Generation Sequencing Laboratory for Private and Public Customers
PR-M01-20-NI-014
Facility Design
Strategic Facility Planning for Cell and Gene Therapy Facilities
PAP-Q3-19-CL-009
Gene Therapy
Slow Progress and a Shaky Start—What’s Next for Gene Therapy?
PAP-Q4-19-NI-001
Gene Therapy
Introduction: The Promise & Challenge of Gene Therapy
PAP-Q4-19-NI-008
Gene Therapy
Gene Therapy R&D Accelerates
PAP-Q4-19-NI-002
Gene Therapy
Overcoming the Manufacturing Roadblock
PAP-Q4-19-NI-003
Gene Therapy
Promise Amid Challenges: Logistics of the Cell and Gene Therapy Supply Chain
PAP-Q4-19-NI-004
Cell Therapy
CD34+ Cell Therapy in Clinical Trials
PAP-Q4-19-CL-012
Ophthalmology
Innovative Therapies to Treat Rare and Underserved Eye Diseases
PAP-Q4-19-CL-025
Plasmids
The Pivotal Role of Plasmid DNA
PAP-Q4-19-CL-006
Gene Therapy
Ferring and Blackstone Life Sciences Invest Over $570 Million USD in Novel Gene Therapy for Bladder Cancer Patients
PR-M11-19-NI-032
Cell and Gene Therapy
FUJIFILM Diosynth Biotechnologies Announces $55 Million Investment to Expand Gene Therapy Development Capabilities
PR-M11-19-NI-013
Drug Pricing
Gene Therapy Payment Questions Linger
PAO-M11-19-NI-003
AAV Vector Production
Production of AAV Vectors Using Suspension Mammalian and Insect Cell Systems
PAP-Q3-19-CL-006
Investment
Pfizer Invests Half Billion Dollars to Advance State-of-the-Art Gene Therapy Facility in Sanford, North Carolina
PR-M08-19-NI-079
CRISPR
Scientists Edit Stem Cell–Derived Neurons Using CRISPR
PAO-M08-19-NI-039
CRISPR-Cas
Editing Many Sites at Once With CRISPR-Cas
PAO-M08-19-NI-032
«
4
10
»
.svg)
